JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, vol.51, pp.506-512, 2019 (SCI-Expanded)
Article / Article
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Olopatadine hydrochloride, Nanoparticles, Ocular application, Drug delivery system, Sustained release, POLYMERIC NANOPARTICLES, DRUG-RELEASE, CHITOSAN NANOPARTICLES, CELLULAR UPTAKE, PART II, SYSTEMS, TEAR, EYE, FABRICATION, ADSORPTION
Anadolu University Affiliated:
Introduction: Allergic eye diseases includes a spectrum of diseases, with each state being characterized by a complicated immunopathology. In the present study, polymeric Kollidon (R) SR nanoparticles loaded with olopatadine hydrochloride (OLO) were formulated as a suspension for ocular drug delivery. The formulations were developed to treat ocular allergic disease and characterized by their improved duration of corneal retention.